Business Wire

Arrowhead Pharmaceuticals Announces Pricing of $450.0 Million Underwritten Offering of Common Stock

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the pricing of an underwritten registered offering of 15,790,000 shares of its common stock, par value ...
Business Insider

Arrowhead price target lowered to $38 from $51 at B. Riley

B. Riley lowered the firm’s price target on Arrowhead (ARWR) to $38 from $51 and keeps a Buy rating on the shares following the fiscal Q1 report. The firm says Ionis Pharmaceuticals’ (IONS) Tryngolza ...
Nasdaq

Arrowhead Pharmaceuticals (ARWR) Price Target Increased by 17.24% to 59.24

The average one-year price target for Arrowhead Pharmaceuticals (NasdaqGS:ARWR) has been revised to $59.24 / share. This is an increase of 17.24% from the prior estimate of $50.53 dated November 14, ...
Hosted on MSN

Arrowhead options imply 11.3% move in share price post-earnings

Pre-earnings options volume in Arrowhead (ARWR) is 1.2x normal with calls leading puts 13:1. Implied volatility suggests the market is anticipating a move near 11.3%, or $5.26, after results are ...